Publikation

Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer

Wissenschaftlicher Artikel/Review - 13.09.2021

Bereiche
PubMed
DOI

Zitation
Stoll S, Unger S, Azzarello-Burri S, Chappuis P, Graffeo R, Pichert G, Röthlisberger B, Taban F, Riniker S. Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer. Swiss Med Wkly 2021; 151:w30038.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Swiss Med Wkly 2021; 151
Veröffentlichungsdatum
13.09.2021
eISSN (Online)
1424-3997
Seiten
w30038
Kurzbeschreibung/Zielsetzung

This paper presents the Swiss guideline for genetic counselling and testing of individuals with an increased probability for carrying mutations in high risk cancer predisposition genes, particularly BRCA1 and BRCA2. It aims to help providers of genetic counselling to identify valuable candidates for testing and serves as a basis for reimbursement claims to Swiss insurance companies.